Few families receive a straightforward and immediate diagnosis of hypochondroplasia. Most may hear comments such as: "Your child may have achondroplasia, hypochondroplasia, or another form of dwarfism, skeletal dysplasia, short stature, or growth disorder," or "There are features we would like to investigate further," or even, "Your child has short stature and we are not yet sure why." At this stage, clear information can help families understand what doctors may be looking for, what tests could come next, and how to take an active part in the diagnostic process.
Hypochondroplasia is not always easy to recognize. Families may notice certain signs that lead to medical investigation. Understanding the diagnostic process is important, as it may involve various evaluations to confirm the condition.
It may be diagnosed at various stages of life. For some it is before birth, while others are diagnosed during infancy or early childhood. In some cases, the diagnosis may not be confirmed until later childhood or even adulthood.
In 2026, an international group of clinicians, skeletal dysplasia specialists, radiologists, geneticists and patient representatives published the first international consensus recommendations for diagnosing hypochondroplasia. The objective is to help doctors recognize HCH earlier and diagnose it more consistently You may wish to read and share the paper with your medical team, it can be downloaded from here.
There is no single feature or test that confirms hypochondroplasia in everyone. The 2026 recommendations set out major and minor diagnostic criteria for hypochondroplasia. These include clinical and body measurements, X-ray findings, genetic testing and, in some circumstances, brain MRI findings.
Some of these findings are age-dependent and may be subtle in infancy, which means that the way HCH is investigated can differ depending on a person’s age.
The criteria are grouped as major and minor, and specific combinations of these findings together with genetic results are used to establish a definitive or suspected diagnosis.
Family history is also important. A parent, sibling or child with definitive or suspected HCH can contribute to the diagnostic assessment. Sometimes the diagnosis of one family member leads to HCH being recognized in other relatives, and people within the same family can have quite different heights and features
In some families, hypochondroplasia may be suspected during pregnancy, particularly when there is a known family history of HCH, when prenatal ultrasound identifies features suggesting a skeletal dysplasia, or when prenatal genetic screening or testing is performed.
The prenatal ultrasound findings most commonly associated with hypochondroplasia are shortening of the long bones and relative macrocephaly, meaning that the head is relatively large compared with overall body size. These features may be visible from around 20 weeks of pregnancy and can become more noticeable between 24 and 28 weeks.
However, prenatal signs can be subtle. Measurements may still fall within the usual range, and many babies with hypochondroplasia are not diagnosed before birth.
In some countries, non-invasive prenatal screening (NIPS) can screen for selected single-gene conditions, including some FGFR3 variants associated with hypochondroplasia. Availability varies between countries and healthcare systems.
NIPS is a screening test, not a diagnostic test. If screening identifies an FGFR3 variant associated with HCH, confirmatory diagnostic testing may be offered during pregnancy or after birth.
When there is already HCH in the family, the available testing options may depend on which parent has HCH. Families can discuss the most appropriate approach with their healthcare provider or genetic counsellor.
If HCH is still suspected after birth despite a negative prenatal screening result, or if prenatal genetic testing was not performed, the baby can still be assessed after birth.
Some babies show features shortly after birth that prompt further investigation for conditions like hypochondroplasia. These may include shorter arms and legs in proportion to the body, or a larger head relative to body size. A history of a seizure not associated with fever may also contribute to the diagnostic assessment.
Other babies may have no obvious features at birth, with differences becoming more apparent over time. Not every child with hypochondroplasia will have these features, and some infants may come to medical attention because of their growth pattern alone.
Growth and body proportions
Body measurements can provide useful information from birth. In babies and young children, doctors may compare the upper part of the body with the lower part of the body using the upper-to-lower body segment ratio. This can help identify disproportion even when a baby’s overall length is still within the usual range.
Another important feature is relative macrocephaly, meaning that the head is larger in relation to the child’s length or height. A baby with HCH does not necessarily have a head circumference outside the usual range. What matters is the relationship between head size and body length or height. Doctors can assess this using the Head Circumference–Height Index (HCH-I).
X-rays in babies
X-rays can provide useful information, however, some of the most characteristic HCH findings may be subtle or not yet be present in babies under 12 months. These findings are best reviewed by a radiologist or clinician with experience in skeletal dysplasias.
The 2026 international consensus paper includes a specific set of X-ray findings for babies under 12 months. At least two of these findings are needed to meet the minor radiographic criterion::
- short sciatic notches in the pelvis
- short, relatively broad long bones
- broad femoral necks
- more horizontal acetabular roofs at the hips
- small iliac bones in the pelvis
The characteristic lower-spine findings used as a major diagnostic criterion are assessed from 12 months onwards.. This is important because an X-ray taken very early in life may not yet show the changes that become more characteristic later. If HCH continues to be suspected and early X-rays are unclear, repeat X-rays may be considered later as the child grows. More information about repeat imaging is included in the next section.
Genetic testing
If hypochondroplasia is suspected during infancy, FGFR3 genetic testing may be considered. Genetic findings are interpreted together with the clinical measurements and imaging findings.
If previous testing does not find an HCH-associated FGFR3 variant but there is still strong reason to suspect HCH, doctors may review what testing was performed and consider whether more comprehensive genetic testing is appropriate.
What about brain MRI?
A brain MRI is not routinely required simply to diagnose hypochondroplasia when the other diagnostic criteria are met. MRI may be recommended when there is a clinical reason, such as seizures, developmental concerns or increasing head circumference.
If a brain MRI has already been performed, certain findings can contribute to the diagnostic criteria. These include changes involving the temporal lobes and hippocampus, such as incomplete hippocampal inversion, sometimes called hippocampal malrotation. Other findings, such as ventriculomegaly or increased extra-axial fluid, may also provide additional diagnostic information.
Brain MRI findings can also be subtle and should be interpreted in the context of the person’s clinical history by clinicians familiar with HCH and skeletal dysplasias.
The important point for families is that MRI findings can be useful when they are present, but a brain MRI is not required for every baby being assessed for HCH
For many children, hypochondroplasia becomes easier to recognize during late infancy or early childhood. Differences in height and body proportions may become more noticeable as they grow, and X-ray findings can become more characteristic with age.
Children with HCH can vary considerably in height and proportions. Doctors therefore look at growth over time as well as body proportions, rather than height alone.
Growth and body proportions
Measurements that may contribute to the diagnostic assessment include:
- height and growth over time
- height compared with the height expected based on the parents' heights
- sitting height in relation to standing height
- upper-to-lower body segment ratio
- head circumference in relation to height
As described above, head circumference may be within the usual range but relatively large compared with the child's height.
Doctors may also assess the arms and hands, including arm span in relation to height, shorter upper arms, reduced ability to fully straighten the elbows, and broad or shorter hands.
X-rays from 12 months onwards
These findings can be subtle and are best reviewed by a radiologist or clinician with experience in skeletal dysplasias.
From 12 months of age, X-rays of the lower spine can provide particularly useful diagnostic information.
One of the major diagnostic criteria is a characteristic combination of findings in the lumbar spine:
- on a front-facing X-ray, the normal widening of the space between the vertebral pedicles from L1 to L4 is reduced or absent
- on a side-view X-ray, the lumbar pedicles become progressively shorter from L1 to L4
Both of these lower-spine findings together make up the major X-ray criterion from 12 months onwards.
Other X-ray findings can also contribute to the diagnosis, including:
- a relatively long fibula near the ankle
- small iliac bones in the pelvis
- short or broad femoral necks
- short, relatively broad long bones
- flaring at the ends of some long bones
- prominent areas where muscles attach to the bones
At least two of these findings are needed to meet the minor X-ray criterion. In children aged 3 years and older, a relatively long fibula near the ankle must be one of them.
What if earlier X-rays were inconclusive?
HCH features on X-rays can become clearer with age. An X-ray taken during infancy or early childhood may therefore not show all of the findings seen later. If HCH is still suspected and earlier X-rays did not provide a clear answer, repeat radiographic assessment may be considered one year later or after the child’s third birthday, whichever is later.
Other findings that may contribute
A history of at least one seizure not associated with fever can also contribute to the diagnostic assessment.
In children old enough for these differences to be assessed, ADHD, diagnosed learning difficulties or executive-function differences can also contribute. These features are not present in everyone with HCH and are not required for diagnosis.
If a brain MRI has already been performed for a clinical reason, characteristic findings involving the temporal lobes or hippocampus may also contribute to the diagnostic assessment. Brain MRI is not routinely required solely to diagnose HCH.
Some children with hypochondroplasia may not receive a diagnosis until school age or later. The features can be relatively subtle earlier in life, height may overlap with the usual range, and HCH may not initially be considered. Some people may previously have been described as having familial short stature or unexplained (idiopathic) short stature without a specific diagnosis.
As a child grows, differences in height and body proportions may become easier to recognize. During adolescence, the pubertal growth spurt may be smaller or absent, which can make differences in height and proportions more noticeable.
What doctors may look at
- height and growth over time
- height compared with the height expected based on the parents' heights
- sitting height in relation to standing height
- arm span in relation to height
- head circumference in relation to height
- upper-to-lower body segment ratio
- shorter upper arms
- broad or shorter hands
- reduced ability to fully straighten the elbows
- family history of hypochondroplasia or similar features
A person does not need to have all of these features for HCH to be considered.
X-rays
By later childhood, characteristic skeletal findings of HCH may be easier to assess than they were in infancy.
The same major lumbar-spine X-ray criterion described from 12 months onwards continues to apply in older children and adults. Other findings involving the fibula, pelvis, femoral necks and long bones can also contribute to the minor radiographic criterion.
These findings can be subtle and are best reviewed by a radiologist or clinician with experience in skeletal dysplasias.
If X-rays taken earlier in childhood were inconclusive, the medical team may review previous images or consider whether repeat imaging would be useful.
Learning, attention and seizures
In older children and adults, ADHD, diagnosed learning difficulties or executive-function differences can contribute as a minor diagnostic criterion.
A history of at least one seizure not associated with fever can also contribute. These features are not present in everyone with hypochondroplasia and are not required for diagnosis.
Genetic testing later in life
Genetic testing can be helpful at any age. If previous testing did not identify an HCH-associated FGFR3 variant, it can be useful to check what type of testing was performed, particularly if the testing was done some time ago or only looked for selected variants.
More comprehensive FGFR3 testing or broader genetic testing may be considered where appropriate.
Can HCH be diagnosed in adulthood?
Yes. Some people with milder features are first diagnosed in late childhood or adulthood. Adults may first be investigated because of short stature, body proportions, back or limb symptoms, or after a child or another relative receives an HCH diagnosis.
There is no age at which it is too late to investigate possible hypochondroplasia.
A diagnosis in adulthood can still provide useful information about a person's health, genetics, family history and the healthcare that may be relevant to them.
etic testing looks for changes in the FGFR3 gene, the gene associated with hypochondroplasia.. Identifying the genetic cause of a skeletal dysplasia such as HCH can help clarify the diagnosis, guide monitoring and healthcare, and distinguish it from other conditions with similar growth or skeletal features.
A genetic test may find:
- a pathogenic variant, meaning there is strong evidence that the genetic change causes HCH
- a likely pathogenic variant, meaning the evidence strongly suggests that it causes HCH
- a variant of uncertain significance (VUS), where there is not yet enough evidence to know whether the genetic change causes HCH
- no HCH-associated FGFR3 variant detected
The genetic result is considered together with the other diagnostic criteria. A result showing a pathogenic or likely pathogenic FGFR3 variant can help confirm the diagnosis when the required clinical criteria are also present.
What if FGFR3 testing is negative?
A negative genetic test does not always completely rule out hypochondroplasia. Studies have found that some people with clinical features of HCH do not have an identifiable FGFR3 variant, and the type of genetic testing performed can also make a difference.
If HCH is still suspected, it can be useful to find out exactly what the previous genetic test looked for. Some tests may only examine selected FGFR3 variants or parts of the gene. In these situations, doctors may consider:
- reviewing the original genetic test
- repeating or carrying out more comprehensive FGFR3 testing
- discussing the result with a specialist skeletal dysplasia genetics laboratory
- testing other genes associated with similar growth and skeletal features
- broader testing, such as a skeletal dysplasia gene panel, exome sequencing or genome sequencing
Other genes that can have features overlapping with HCH include SHOX, ACAN, GNAS, NPR2, COL2A1 and IHH.
What if a VUS is found?
A variant of uncertain significance, often shortened to VUS, means that a genetic change has been found, but there is not yet enough evidence to know whether it causes HCH.
A VUS is therefore not the same as a confirmed genetic diagnosis. Its interpretation can change as scientific knowledge grows. In some cases, looking at whether the same variant is present in other family members, reviewing the clinical features of parents, or reassessing the variant at a later date can provide additional information.
This is particularly important in HCH because new FGFR3 variants continue to be described, and some variants that cannot be clearly interpreted today may be better understood in the future.
HCH can still be suspected without a confirmed genetic result
The diagnostic criteria recognize that not everyone being assessed for HCH will immediately have a definitive genetic diagnosis. A diagnosis of suspected hypochondroplasia can be made in certain circumstances when a VUS is found, when a likely pathogenic FGFR3 variant is found but the criteria for a definitive diagnosis are not met, or when no FGFR3 variant is detected but several major diagnostic criteria are present. People with suspected HCH may need further clinical or genetic evaluation and later review of genetic findings.
This allows clinical measurements, X-rays, family history and other diagnostic findings to continue to inform the assessment rather than relying on a genetic result alone. People with suspected HCH may also benefit from further clinical or genetic evaluation and, where relevant, later review of genetic findings.
Free genetic testing programs
In the United States and Canada, some children with suspected skeletal dysplasia may be eligible for sponsored genetic testing at no cost to families.
One example is the Discover Dysplasias™ program, which provides no-charge genetic testing and genetic counselling for eligible children aged 16 years and younger with short stature and additional features suggestive of a skeletal dysplasia. Testing must be ordered by a healthcare provider and eligibility criteria apply.
Not everyone being assessed for HCH will receive a definitive diagnosis after the first investigations.
The 2026 criteria recognize suspected hypochondroplasia as a diagnostic category. They also include hypochondroplasia, genetically unconfirmed for specific situations where sufficient major clinical criteria are present but genetic testing has not been performed or is unavailable.
If HCH continues to be suspected, further clinical or genetic assessment may be appropriate. This can include reviewing previous X-rays or genetic testing, carrying out additional investigations, repeating age-dependent assessments when appropriate, and periodically reviewing the interpretation of a genetic variant.
If you or your child are being assessed for possible hypochondroplasia, it may be helpful to bring to your appointment:
- previous height and growth measurements or growth charts
- previous head circumference measurements, if available
- parents’ heights
- previous X-rays and radiology reports
- copies of previous genetic test results
- brain MRI reports and MRI images if an MRI has already been performed
- information about relatives with HCH, short stature or similar body proportions
relevant developmental, neurological or educational assessments
- You may also wish to share the 2026 international consensus recommendations for diagnosing hypochondroplasia with your healthcare professional.
Questions you may want to ask
- What makes you think this could be hypochondroplasia?
- Could my child’s or my growth and body proportions fit HCH?
- Has head circumference been considered in relation to height?
- Do the X-rays show any of the age-specific findings associated with HCH?
I- f earlier X-rays were inconclusive, would reviewing or repeating them be useful?
- What exactly did the genetic test examine?
I- f FGFR3 testing was negative, could more comprehensive genetic testing be appropriate?
- If a VUS was found, should it be reviewed again?
- Could family history provide useful information?
- Would referral to a clinician or centre with experience in skeletal dysplasias be useful?
he diagnostic process can bring a mix of emotions. Some families may feel worried or frustrated by not having a clear answer, while others may feel relief when there is finally an explanation for differences they have noticed for some time. There is no single way to feel about a possible diagnosis.
A diagnosis can provide useful information about healthcare, growth and development, and make it easier to connect with others who have similar experiences.
While you are waiting for answers, it is reasonable to ask questions, request copies of test results and imaging reports, seek another medical opinion when needed, and ask for referral to someone with experience in skeletal dysplasias.
Resources and community
Finding accurate information and connecting with other people who understand hypochondroplasia can be helpful during the diagnostic process.
The Hypochondroplasia Foundation provides information and resources for people with HCH and their families, including:
- information about diagnosis, healthcare and everyday life
- publications and patient-friendly medical information
-opportunities to connect with other families and adults with HCH
- updates on research and developments in hypochondroplasia
- information to help families prepare for conversations with healthcare professionals
If you are currently seeking a diagnosis, you are welcome to connect with the Hypochondroplasia Foundation community at any stage of the process, whether HCH has been confirmed, is suspected, or you are still looking for answers.
Many families find that uncertainty becomes easier to manage as they gain information, build a healthcare team, and connect with others who have been through a similar experience.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.